Veterinary Medicines

Fenoflox 100 mg/ml Solution for Injection for Cattle and Pigs

Not authorised
  • Enrofloxacin
Download as PDF

Product identification

Medicine name:
Fenoflox 100 mg/ml Solution for Injection for Cattle and Pigs
Active substance:
  • Enrofloxacin
Target species:
  • Pig
  • Cattle
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Enrofloxacin
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        13
        day
  • Intravenous use
    • Cattle
      • Meat and offal
        5
        day
      • Milk
        3
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        12
        day
      • Milk
        4
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Belgium
Package description:
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 100 ml No. of containers in a carton: 1 x 100 ml
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 100 ml No. of containers in a carton: 5 x 100 ml
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 100 ml No. of containers in a carton: 10 x 100 ml
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 100 ml No. of containers in a carton: 12 x 100 ml
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 100 ml No. of containers in a carton: 15 x 100 ml
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 100 ml No. of containers in a carton: 20 x 100 ml
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 250 ml No. of containers in a carton: 1 x 250 ml
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 250 ml No. of containers in a carton: 5 x 250 ml
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 250 ml No. of containers in a carton: 10 x 250 ml
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 250 ml No. of containers in a carton: 12 x 250 ml
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 250 ml No. of containers in a carton: 15 x 250 ml
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 250 ml No. of containers in a carton: 20 x 250 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Labiana Life Sciences S.A.
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V363081
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0223/002